Test Directory

Test Code
1629
Test Name
Polydactyly, Preaxial IV & Postaxial, Type A1
CPT Codes
81479
Expected Turnaround Time
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Clinical Utility
Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members.
Specimen and Container Info

Non-Prenatal Specimens

Preferred/Alternate

Specimen Type

Containers

Volume

Preferred Specimen Type

Whole Blood

Lavender Top (EDTA)

3 mL

Alternate Specimen Type

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Alternate Specimen Type

Fibroblasts

T-25 Flasks

2 confluent T-25 flasks, filled to capacity

Alternate Specimen Type

Saliva (Whole blood is recommended for CNV)

DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children

Follow kit instructions (www.dnagenotek.com)

Prenatal Specimens

Either specimen type below is acceptable.

Specimen Type

Containers

Volume

Cultured cells

T-25 Flasks

2 confluent T-25 flasks derived from amnio or CVS samples.

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico.

Transport Instructions
  • Transport at room temperature within 24 hours.
  • If the specimen cannot be transported to the lab within 24 hours, refrigerate for up to 72 hours.
  • Do not freeze or expose to extreme temperatures, refrigerate for up to 72 hours if cannot be transported to lab within 24 hours. 
Stability Requirements

Room Temperature

24 hours

Refrigerated

72 hours

Causes for Rejection
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Next Generation Sequencing and Copy Number Variation Analysis
Performing Location
Genomics - Snowdrift
Description

GLI3 related disorders - Greig cephalopolysyndactyly syndrome (GCPS; MIM 175700), Pallister-Hall syndrome (PHS: MIM 146510), polydactyly, postaxial, type A1 (PAPA1; MIM 174200) and polydactyly, preaxial IV (MIM 174700) are allelic, autosomal dominant disorders caused by mutations in the GLI3 gene. GLI3 encodes a zinc finger transcription factor.

GCPS has variable clinical findings. The primary findings in GCPS include polysyndactyly, macrocephaly and hypertelorism. Polydactyly may occur in any limb with postaxial polydactyly of the hands and preaxial polydactyly of the feet being observed most frequently. Less common findings include inguinal, umbilical or diaphragmatic hernia, craniosynostosis, downslanting palpebral fissures and rare instances of mental retardation and agenesis of the corpus callosum. It has been stressed that not all GCPS patients have the typical findings and that the presentation may be quite subtle. GCPS is caused by loss of function mutations in GLI3. These include rare translocations, small and large deletions, small and large insertions, nonsense, missense and splicing mutations. More than 75% of patients with GCPS are expected to have a definable GLI3 mutation.

PHS is a pleiotropic disorder characterized by hypothalamic hamartoma, mesoaxial (central) polydactyly or postaxial polydactyly and bifid epiglottis. Many additional findings have been reported in PHS including: imperforate anus, nail hypoplasia, genital hypoplasia, dental hypoplasia, developmental delay, kidney dysplasia or dysfunction, hypothyroidism and hormonal abnormalities. Significant inter- and intrafamilial variation is observed in PHS. PHS seems to be caused by truncating mutations in GLI3. These include, small insertions, duplications and deletions, splice site and nonsense mutations. At least 90-95% of PHS patients are expected to have a detectable GLI3 mutation.

PAPA1 includes postaxial, polydactyly type B (PAPB). In PAPA1 the extra digit is well formed and articulates with the fifth or an extra metacarpal. In PAPB the extra digit is not well formed and may be represented by a skin tag. Both PAPA1 and PAPB have been reported in the same pedigrees. Postaxial polydactyly types A1 and B are reported to be about 10 times more common in African Americans than in Caucasians.

Polydactyly, preaxial IV is characterized by mild thumb duplication, variable syndactyly of the 3rd and 4th fingers, partial or complete duplication of the 1st or 2nd toes and syndactyly of all toes. Polydactyly, preaxial IV is probably synonymous with crossed polydactyly type 1. Phenotypic variation has been observed in polydactyly, preaxial pedigrees with defined GLI3 mutations.

Testing Schedule
Monday-Friday
Genes
GLI3
MIM
174700
Disease Group
Skeletal Disorders